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Abstract: 
Direct injection-mass spectrometry (DIMS) can be used to perform high-
throughput metabolomic fingerprinting. This work aims to evaluate a global 
analytical workflow in terms of sample preparation (urine sample dilution), 
high resolution detection (quality of generated data based on criteria such 
as mass measurement accuracy and detection sensitivity) and data 
analysis using dedicated bioinformatics tools. Investigation was performed 
on a large number of biological samples collected from sheep infected or 
not with scrapie.  
DIMS approach is usually affected by matrix effects, eventually hampering 
detection of some relevant biomarkers. Reference compounds were spiked 
in biological samples to help evaluate the quality of DIMS data produced by 
Fourier Transform mass spectrometry (FTMS). Despite the potential of high 
resolution detection, some drawbacks still remain. The most critical is the 
presence of matrix effects, which could be minimized by optimizing the 
sample dilution factor. The data quality in terms of mass measurement 
accuracy and reproducible intensity was evaluated. Good repeatability was 
obtained for the chosen dilution factor (i.e. 2000). More than 150 analyses 
were performed in less than 16 hours using the optimized DIMS approach. 
Discrimination of different status of sheeps in relation to scrapie infection 
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(i.e. scrapie-affected, preclinical-scrapie or healthy) was obtained from the 
application of Shrinkage Discriminant Analysis (SDA) to the DIMS data. The 
most relevant variables related to this discrimination were selected and 
annotated.  
This study demonstrated that the choice of appropriated dilution faction is 
indispensable for producing quality and informative DIMS data. Successful 
application of DIMS approach for high throughput analysis of a large 
number of biological samples constitutes the proof of the concept.  
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Abstract  
Direct injection-mass spectrometry (DIMS) can be used to perform high-throughput 
metabolomic fingerprinting. This work aims to evaluate a global analytical workflow in terms 
of sample preparation (urine sample dilution), high resolution detection (quality of generated 
data based on criteria such as mass measurement accuracy and detection sensitivity) and data 
analysis using dedicated bioinformatics tools. Investigation was performed on a large number 
of biological samples collected from sheep infected or not with scrapie. 
DIMS approach is usually affected by matrix effects, eventually hampering detection of some 
relevant biomarkers. Reference compounds were spiked in biological samples to help evaluate 
the quality of DIMS data produced by Fourier Transform mass spectrometry (FTMS). Despite 
the potential of high resolution detection, some drawbacks still remain. The most critical is 
the presence of matrix effects, which could be minimized by optimizing the sample dilution 
factor. The data quality in terms of mass measurement accuracy and reproducible intensity 
was evaluated. Good repeatability was obtained for the chosen dilution factor (i.e. 2000). 
More than 150 analyses were performed in less than 16 hours using the optimized DIMS 
approach. Discrimination of different status of sheeps in relation to scrapie infection (i.e. 
scrapie-affected, preclinical-scrapie or healthy) was obtained from the application of 
Shrinkage Discriminant Analysis (SDA) to the DIMS data. The most relevant variables 
related to this discrimination were selected and annotated. 
This study demonstrated that the choice of appropriated dilution faction is indispensable for 
producing quality and informative DIMS data. Successful application of DIMS approach for 
high throughput analysis of a large number of biological samples constitutes the proof of the 
concept.  
 
Keywords: High-throughput metabolomics, Direct injection-mass spectrometry, High 
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Introduction 
 
Metabolomics
1-2 
refers to the large-scale study of small-molecule metabolites present in a 
biological system (e.g., cell, tissue or biofluid). It studies metabolic profile changes, which 
may reflect metabolic disruptions induced by environmental stress or diseases, with the 
objective of detecting metabolic biomarkers. Nuclear magnetic resonance (NMR)
3
 and mass 
spectrometry (MS)
4-7
 are the analytical technologies generally used to produce metabolomic 
data. These techniques enable simultaneous analysis of a large set of metabolites in a single 
experiment. Although NMR has demonstrated its high potential in measurement 
reproducibility, its sensitivity remains a weak point compared to that of MS. Thanks to its 
sensitivity, selectivity and specificity, MS has become an efficient analytical platform in 
metabolomics. Its coupling to a separation technique like gas chromatography (GC),
8
 liquid 
chromatography (LC)
9
 or capillary electrophoresis (CE)
10
 is usual practice, providing 
separation of isobaric and/or isomeric compounds and also reduction of matrix effects. 
However, such coupling techniques involve relatively long analysis times, limiting the 
throughput of analyses, especially technical drifts occur when performing large scale analyses 
such as in cohort studies. 
Direct injection mass spectrometry (DIMS) is an attractive alternative to perform high-
throughput metabolomic analyses.
11
 For a long time direct analysis of biological samples has 
been successfully performed using pyrolysis mass spectrometry
12,13 
as well as electrospray 
ionization coupled to mass spectrometry (ESI-MS).
14-19
 ESI is a soft desorption/ionization 
method well adapted for polar molecule analysis, providing controlled and limited in-source 
fragmentations of charged molecular species.
20
 It is one of the most suitable techniques for 
high throughput DIMS approach and the most often used in metabolomics because of the 
polar character of most metabolites.
14-19
 
DIMS usually involves high resolution mass spectrometry (HRMS).
11,18,21,22
 HRMS 
technology offers a way to replace conventional chromatographic separation of molecules by 
compound distinction according to their accurate ion m/z values. Typically, Fourier transform 
mass spectrometer (FTMS) is used, providing high mass resolving power and distinction of 
isobaric species.
23
 Its capacity to accurately measure m/z values with ppm error levels 
facilitates the assignment of elemental compositions of biomarker candidates. In addition, 
high dynamic mass range of FTMS instrumentation enables simultanous detection of large 
number of metabolites present over a wide range of concentrations. DIMS approach using ESI 
source and FTMS detection has been successfully employed in several fields, e.g., biological 
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fluid analysis,
24,25
 plant metabolomic studies
26
 and microbial applications.
27
 Although DIMS 
approach does not allow exhaustive analysis of all metabolites present in a biological sample 
even using the most powerful FTMS technology, detection of only metabolic profile change 
(i.e. some discriminant metabolites or specific endogenous compound signal variations) 
should be sufficiently indicative to qualify a global metabolic disruption or some coordinated 
metabolic changes associated to the progression of a disease. ESI is highly susceptible to 
matrix effects, i.e. signal suppression or enhancement phenomena due to matrix components, 
which alter the ionization efficiency and can hamper detection of some (eventually 
discriminant) compounds.
28,29
 Thus, the use of ESI technique for direct analysis of complex 
mixtures is very challenging. The first step of analytical workflow implies the choice of the 
best sample preparation conditions.
30
 The separation of matrix components from target 
analyte(s) could be done during the sample preparation or purification step to limit these 
matrix effects. However, these processes are less suitable for metabolomic fingerprinting, 
which aims, as much as possible, for an exhaustive detection of metabolites. Nevertheless, for 
urine samples the dilution constitutes an easy way of minimizing, although not totally 
eliminating the matrix effects.  
The objective of this work is to demonstrate the efficiency of DIMS approach using ESI 
technique and an LTQ-Orbitrap instrument
31
 for acquiring high-throughput metabolomic 
fingerprints from a large set of biological samples. The evaluation of different critical aspects 
such as selectivity, specificity, linearity, sensitivity and repeatability of analytical method was 
first performed. Finally, a large number of biological samples (i.e. more than 150 samples) 
collected in sheep infected or not with scrapie were analyzed using our direct approach. The 
generated spectral data were subsequently analyzed using multivariate statistical analysis, 
providing the discrimination of animals according to their health status (healthy control, 
preclinical and clinical scrapie-infected sheeps).  
 
Materials and Methods 
Animals 
Urines were collected from healthy, preclinical and scrapie-infected ewes with a diagnosis 
confirmation as published previously.
32
 Samples were stored at -20°C until analysis. 
 
Material 
HPLC-grade methanol was purchased from VWR International S.A.S. (Fontenay-sous-Bois, 
France) and ultrapure water was provided by a Milli-Q system (Millipore, Molsheim, France). 
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Three reference compounds were used to evaluate the quality of data produced by DIMS: 
isoniazid (C6H7N3O, Mw 137.0589 u) and oxytetracycline (C22H24N2O9, Mw 460.1482 u) 
were purchased from Sigma–Aldrich Chimie (Saint-Quentin Fallavier, France) and 2-amino-l-
methyl-6-phenylimidazo [4,5-b] pyridine (PhIP, C13H12N4, Mw 224.1062 u) was obtained 
from Toronto Research Chemicals (Ontario, Canada). 
All urine samples were centrifuged and the supernatants were collected. First two urine 
samples (one from a healthy sheep and another from a scrapie-affected sheep) were diluted in 
CH3OH/H2O (50:50, v/v) solvent mixture at different dilution factors (i.e. 100, 500, 1000, 
2000, 3000 and 5000). Based on the preliminary results from dilution study, all urine samples 
were prepared in the same conditions at a fixed dilution factor (i.e. 1:2000). All samples were 
spiked with the three reference compounds at final concentrations of 5 ng/µL for isoniazid 
and oxytetracycline, and 0.05 ng/µL for PhIP. 
 
Analytical methods 
Mass spectrometry experiments were performed using an LTQ-Orbitrap-XL hybrid 
instrument
 
(Thermo Fisher Scientific, Villebon sur Yvette, France) equipped with an ESI 
source operated in positive ion mode.
33
 
All mass spectra were recorded in the 100-1000 m/z range. The Ion Trap and FTMS Full 
AGC (automatic gain control) target values were set at 1 x 10
4
 and 2 x 10
5
, respectively and 
the ion trap and FTMS Full Max ion times at 50 ms and 200 ms, respectively. Mass 
measurements were performed with a theoretical mass resolving power of 100,000 FWHM 
(full width at half maximum) at m/z 400. An internal calibration mode (“lock mass”) was 
applied based on impurity ions at m/z 236.07157 corresponding to [M+Na]
+
 ions of N-butyl 
benzene-sulfonamide.
34
 
Positive ion source conditions were as follows: electrospray needle, -4 kV; heated transfer 
capillary temperature, 250°C; heated transfer capillary voltage, 30 V, tube lens offset, 100 V; 
sheath gas at a flow rate, 40 % (arbitrary units).  
Flow injection analysis (FIA) mode was used to introduce samples into the mass spectrometer 
through a HP 1100 HPLC system constituting of a quaternary pump and an auto-sampler 
(Agilent, Les Ulis, France). 10 µL of sample were injected in the flow of methanol/water 
isocratic gradient (50:50, v/v) at 30 µL.min
−1
. Mass spectra were recorded for 5 min, 
including a 2.5 min automatic washing step, consisting of an increase of the flow rate to 
200 µL/min after a 2.5 min run. 
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Data processing methods 
A program written in the R 2.15.0 (http://www.R-project.org) was used to process DI-HRMS 
data. From the raw mass spectra, a single large data matrix was generated.  
Data filtering steps were performed to eliminate non-relevant variables and to limit the 
presence of missing values from the resulting matrix. Only ions present in most of the major 
part of samples were selected, i.e. the tail part of the distribution curve when a power law 
distribution is used. 
The resulting data matrix was then processed using Shrinkage Discriminant Analysis
35
 in 
order to distinguish different status of sheeps according to scrapie infection. Canonical 
correlation analysis was also applied to detect the most discriminant variables. Putative ion 
annotation was done using measured accurate m/z values to make queries through Human 
Metabolome Database (HMDB)
36,37
 or METLIN.
38
  
 
Results and discussion 
1. Sample dilution as an efficient way to minimize matrix effects 
The determination of the best conditions for sample preparation was performed in order to 
minimize matrix effects and to obtain a sensitive MS response from analysis of a complex 
mixture containing a wide concentration range of metabolites. Two urine samples constituted 
the quality control (QC) samples used for evaluation and validation of the analytical 
conditions (see experimental section). They were prepared at different dilution levels and 
spiked with the same volume of the solution containing the three reference compounds. Mass 
spectra generated from DIMS approach and FTMS detection are shown in Figure 1. Only 
one spiked reference compound, i.e. isoniazid (STD1) was detected at m/z 138.0658 with 
low abundance (7%) for sheep urine diluted one hundred times (Figure 1a), reflecting strong 
matrix effects through the ion suppression phenomenon. Ionization competition probably 
occurred between matrix components present at high levels and the reference compounds to 
the detriment of the ionization of the latter. The same phenomenon could also impact the 
ionization of some endogenous compounds present in the matrix, including potential 
metabolic biomarkers.
39,40
 The 1:2000 dilution appears to be the best, providing MS response 
better than other dilution samples as shown in Figure 1b. In addition to the three reference 
compound ions (i.e. isoniazid (or STD1), PhIP (or STD2) and oxytetracycline (or STD3) 
detected as [M+H]
+
 species at m/z 138.0658, m/z 225.1133 and m/z 461.1548, respectively), 
a larger number of other intense peaks were detected. At larger dilution factors (i.e. 3000 and 
5000) the ions formed from the two reference STD1 and STD3 compounds (m/z 138.0657 
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and m/z 461.1548) became the most abundant ions, reflecting too high dilution conditions 
(Figure 1c). 
(Figure 1 near here) 
Note that the matrix effects could not be easily detected without addition of the reference 
compounds. However, the use of these reference compounds to optimize the analytical 
conditions does not totally guarantee the detection of all endogenous species as some of them 
could still undergo the matrix effects.  
An interesting way to assess the global analytical response is to examine the relative peak 
intensity variations for most ions (including both reference and endogenous compounds) 
detected in the mass spectra recorded for a given urine sample at different concentrations 
(Figure 1d). The relative intensity values should be less affected by analytical drifts 
compared to absolute abundances and representative of the mass spectrum profile. The 
relative abundances of the most abundant ions increased with increasing dilution factor until 
2,000, indicating the reduction of the matrix effects. Indeed, the largest number of ions with 
relative intensities higher than 10 % was obtained for the 1:2000 dilution. Higher sample 
dilution resulted in a decrease in relative intensities for most ions, reflecting the dilution 
effects. 
Alternatively, relative intensities of some ions were plotted as a function of sample 
concentration to examine ion behavior through sample dilution. Different trends are observed 
in the Figure 2. This suggests that the matrix effects depend on the ionic species considered 
and thus on their structure. For example, some ions having relatively high abundance at the 
1:100 dilution underwent strong ion suppression phenomena at the 1:500 dilution. 
Nevertheless, most species displayed a bell-sharped curve with the maximum intensity at a 
dilution factor of 2,000 as confirmed in Figure 2b, which shows the total ion current at 
different dilution factors. 
Investigation was also done for another urine sample and similar results were obtained (see 
Figure S1 of the supplementary information), confirming the choice of the dilution factor at 
2,000 and the representativeness of the sample set.  
Note that sample preparation conditions depend on the sample type (e.g., biofluids or tissues) 
and the origin of species (e.g., humans or animals). Thus, each type of matrix should be 
systematically investigated. 
Finally, a 1:2000 dilution was applied for performing metabolomic fingerprinting of sheep 
urines. 
Page 8 of 26
https://mc.manuscriptcentral.com/ems
European Journal of Mass Spectrometry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
8 
 
(Figure 2 near here) 
 
2. Evaluation of the quality of data produced by DI-HRMS  
The use of HRMS instruments provides high selectivity and specificity of detection. In 
addition, a large number of species, among them most isobaric ions can be detected thanks to 
the high mass resolving power and high dynamic mass range of FTMS instruments. Although 
sample dilution minimized matrix effects, the quality of data produced from sample diluted at 
the chosen dilution factor should be examined based on criteria of linearity and repeatability 
of analytical response.  
 
a) Linearity 
Metabolomics aims to detect metabolic profile changes. The measurements of metabolite 
levels in biological samples should provide information about metabolic function and 
evidence eventual metabolic disruptions. Hence, analytical response of every metabolite 
should be representative of its concentration. 
The relative ion abundance variations were examined for randomly selected ions according to 
sample concentration (Figure 3). Good linearity was observed only under high dilution 
conditions (i.e. dilution higher than 1:2000) with satisfactory correlation coefficient values for 
most of the selected ions whatever their abundanc s (as shown in Table S1 of supplementary 
information). Under low dilution conditions, non-linearity was observed, probably due to the 
presence of matrix effects which impact quantitative response. Such observations confirmed 
that the best dilution factor was 2,000.  
 
(Figure 3 near here) 
 
b) Repeatability of the method 
Repeatability of the method used was also evaluated by repeating 20 injections of a same 
urine sample (diluted at 1:2000 and spiked with the three reference compounds). To do this, 
mass spectrum data quality was assessed according to spectral data features, i.e. peak intensity 
and accurate m/z value.  
The first criterion was examined by plotting the relative standard deviations (RSD) of 
absolute intensity of fifty most abundant ions from the twenty repeated analysis of the same 
sample (see Figure S2 of the supplementary information). Most RSD values were in the 
range of about 20 %. For the twenty five most abundant ions (i.e. with relative intensity 
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greater than 10%), the RSD values were below 10 % (except for one peak). Of course, greater 
variations of peak intensities are unavoidable for lower abundance ions. 
Similar RSD values have been reported with the use of DIMS approach on a 7-T FTICR 
instrument.
41,42
 Kirwan and co-workers
41
 obtained a value of 15.9 % as the median RSD of 
peak intensity after application of computational tools for correcting intra and inter-batch 
variations based on the QC spectra. Similar median RSD values were also obtained without 
any prior computational correction using an instrument equipped with a dynamically 
harmonized Fourier transform ion cyclotron resonance cell.
42 
Here, our results using LTQ-
Orbitrap detection are in the same range. 
 
3. Application of high throughput metabolomics to biological samples 
The global metabolomic workflow includes the optimization of sample preparation 
conditions, the choice of an analytical platform but also bioinformatic tools for pre-processing 
metabolomic data and for selecting biologically-relevant metabolites related to the group 
discrimination. 
The quality of accurate mass measurements was examined for all data based on measured 
accurate m/z values of the spiked reference compound species. The use of internal calibration 
(lock mass) was also tested, providing improvement in the mass measurement accuracy, e.g., 
for m/z 461.1548 protonated oxytetracycline 1.5 ppm mass error was obtained in external 
calibration and error below 0.5 ppm in internal calibration, data not shown). The ‘lock mass’ 
mode was then applied for analysing all biological samples (Figure S3 of the supplementary 
information). A good stability of mass measurement accuracy was also obtained all along the 
analysis time of 159 biological samples during approximately 16 hours. Mass error was 
around 3 ppm for protonated isoniazid at m/z 138.0658 and below 1 ppm for the two other 
reference compound ions at m/z 225.1133 and m/z 461.1548 from oxytetracycline and PhIP, 
respectively. 
After generating sheep urine fingerprints, the first step of data analysis is the pre-processing, 
which consists in transforming the raw data into a matrix suitable for subsequent statistical 
and/or chemometric analyses.
43
 Generated data are often affected by measurement errors due 
to technical variability in terms of mass accuracy drifts and peak intensity variations from 
scan-to-scan and between injections. The presence of missing values and the detection of non-
relevant variables are not favourable for the subsequent statistical analysis. Non-relevant 
signals could arise from artefact signals (e.g., due to Fourier Transform processing of the 
primary signal) or contaminant compounds (e.g., sample preparation contaminants). 
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Otherwise, there are also redundant signals corresponding to different species (i.e. adduct or 
in-source fragment ions) coming from the same compound and usually formed when using 
atmospheric pressure ionization techniques. To eliminate missing values and non-relevant 
variables, a data filtering step was applied to retain only m/z values detected in most of the 
biological samples at a given percentage (i.e. 85 %). This approach is similar that used by 
Taylor et al.
44
 
Here, the distribution of ions was investigated from the data set obtained from urinary 
samples collected on 159 different animals. Surprisingly, from an initial population of 9684 
ions only 122 ions were detected in almost all samples, i.e. with 15% or less of the "non-
availability" in the resulting matrix (Figure S4 of the supplementary information). The global 
distribution of this ion population follows a power law distribution. The 122 variables were 
selected in the heavy tail of such a distribution and used for subsequent statistical analysis 
using a supervised method for discriminant analysis, i.e. Shrinkage Discriminant Analysis 
(SDA)
35
. SDA was applied to a prior corrected dataset using PLS-based orthogonal signal 
correction performed with Simca-P v10.0 (Umetrics, Umea, Sweden) with one component 
considering the health status of animals (3 groups). 
The score plot reported in the Figure 4 shows a visualization of all samples in a two 
dimensional space. A discrimination between the three animal classes (i.e. healthy, 
preclinical-scrapie and scrapie-affected status) was obtained. For example, on the second 
component the healthy animal group is separated from the scrapie-infected one. A leave-one-
out procedure was used to estimate the misclassification ratio at 4.5%, indicating an overall 
metabolic response able to distinguish the animal status. Besides the plot of the probabilities 
coming from the transformation of the Mahalanobis distances
45
 between every statistical 
individual and the barycenter of the 3 phenotype groups (see Figure S5 of the supplementary 
information) can detect some eventual outliers from the data set. The classification property 
of SDA comes from the efficient shrinkage procedure applied on the correlation matrix, the 
covariance matrix and the prior probabilities. Here, few misclassified individuals, i.e. only 7, 
were detected among all individuals (see Figure S5 of the supplementary information). 
Additionally, the canonical correlation analysis was performed to detect more precisely 
variables related to every health status (Figure S6 of the supplementary information). The 
experimental accurate m/z values of these discriminating variables were used to query freely 
available databases (DBs) for putative annotation (Table S2 of the supplementary 
information). Several variables (i.e. different m/z values) could correspond to a same 
metabolite, which reinforce the compound identity assignment. For example, three 
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discriminating variables could be putatively annotated as different forms of creatinine ions: i) 
the protonated ions at m/z 114.0656 annotated as C4H8ON3 with 5.0 ppm error, ii) their 
corresponding 
13
C isotope detected at m/z 115.068 and annotated as 
13
C1C3H8ON3 with 4.3 
ppm error and iii) the m/z 152.0217 [M+K]
+
 adducts annotated as C4H7ON3K with 2.5 ppm 
error. From the fifteen most discriminating variables, nine candidates could proposed with a 
mass measurement accuracy below 5.0 ppm, leading to the putative assignment of the identity 
of six following biomarkers: creatine, creatinine, dideoxyhexitol, glycyl-lysine, methyl-
hippuric acid and octanetriol. Note that according to the canonical correlation protonated 
creatinine ions (including monoisotopic peak at m/z 114.066 and its (M+1)
 
isotope at m/z 
115.068) display a positive correlation with scrapie-infected status whereas negative values 
were observed with samples from healthy animals or those at preclinical stage. 
 
 
(Figure 4 near here) 
 
Conclusions 
This study demonstrates that the investigation for optimizing sample dilution factor is 
essential to minimize matrix effects in order to produce quality and informative DIMS data. 
High throughput analyses can be efficiently performed only after this optimization step. In our 
study, discrimination of different health status (clinical or preclinical-scrapie and healthy) was 
obtained from the generated urinary fingerprints using Shrinkage Discriminant Analysis. This 
study constitutes a proof of concept of the feasibility of DI-HRMS approach for high 
throughput metabolomics at large scale. 
Our approach enabled acquisition of more than 150 metabolomic fingerprints in less than 16 
hours. Such a short analysis time cannot be obtained when using LC/MS approach, even if 
recent ultra-high-performance liquid chromatography (UHPLC) systems allow the decrease of 
LC/MS experiments duration. Rapid production of metabolomic fingerprintings is essential 
when analyzing a large number of samples to limit technical drifts which can impact the 
subsequent statistical analysis.  
Of course, such DIMS approach using low resolution instrument will provide less informative 
data (no distinction of isobaric ions). Instead, the use of higher performance instrumentation 
in terms of mass measurement accuracy and mass resolving power enables separation of very 
close isobaric ions and improves data quality. More, the determination of isotopic fine 
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structures consisting in the identification of the different isotopologues of M+1 and M+2 
isotopic clusters is very useful for metabolomic investigations, particularly for the metabolite 
identity assignment. 
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Figure Captions 
 
Figure 1 Mass spectra of sheep urine samples diluted at a) 1:100, b) 1:2000 and c) 1:5000 and 
spiked with three reference compounds (STD1, STD2 and STD3 corresponding to protonated 
isoniazid, oxytetracycline and 2-amino-l-methyl-6-phenylimidazo [4, 5-b] pyridine (PhIP), 
respectively) (The NL (normalized level) value corresponds to the base peak intensity in 
arbitrary units), and d) plot of relative intensities of the most abundant ions present in the DI-
HRMS mass spectra as a function of dilution factors. For each dilution factor, percentage of 
peaks displaying a relative intensity greater than 10% was reported, suggesting the dilution 
factor of 2,000 as the best 
Figure 2 a) Plot of relative intensities of some ions (with low and high abundances) from DI-
HRMS mass spectra as a function of dilution factor, and b) Total ion current (TIC) at different 
dilution factors (note that the TIC values are calculated from the sum of the relative intensities 
of the 35 most abundant ions) 
Figure 3 Plot of ion relative intensities as a function of sample concentration (i.e. 1:dilution 
factor) from DI-HRMS mass spectra. A linear response was obtained at high dilution 
conditions (i.e. above 1:2000) for most ions with correlation coefficient > 0.988 (see Table 
S1 in supplementary information). Were reported in this plot low and high abundance ions  
Figure 4 Score plot from Shrinkage Discriminant Analysis (SDA) performed on the 122 
selected variables after data pre-processing 
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Mass spectra of sheep urine samples diluted at a) 1:100, b) 1:2000 and c) 1:5000 and spiked with three 
reference compounds (STD1, STD2 and STD3 corresponding to protonated isoniazid, oxytetracycline and 2-
amino-l-methyl-6-phenylimidazo [4, 5-b] pyridine (PhIP), respectively) (The NL (normalized level) value 
corresponds to the base peak intensity in arbitrary units), and d) plot of relative intensities of the most 
abundant ions present in the DI-HRMS mass spectra as a function of dilution factors. For each dilution 
factor, percentage of peaks displaying a relative intensity greater than 10% was reported, suggesting the 
dilution factor of 2,000 as the best  
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a) Plot of relative intensities of some ions (with low and high abundances) from DI-HRMS mass spectra as a 
function of dilution factor, and b) Total ion current (TIC) at different dilution factors (note that the TIC 
values are calculated from the sum of the relative intensities of the 35 most abundant ions)  
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Plot of ion relative intensities as a function of sample concentration (i.e. 1:dilution factor) from DI-HRMS 
mass spectra. A linear response was obtained at high dilution conditions (i.e. above 1:2000) for most ions 
with correlation coefficient > 0.988 (see Table S1 in supplementary material). Were reported in this plot low 
and high abundance ions  
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Score plot from Shrinkage Discriminant Analysis (SDA) performed on the 122 selected variables after data 
pre-processing  
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Table S1. List of some ions detected in the mass spectra acquired at different dilution factors. Their 
linearity response appears in the correlation coefficient value calculated for the highest dilution 
conditions, i.e. above 1:2000). Note that some ions which are not detected in both urine samples. 
This could be due to the difference in the sample groups: the sample 1 is collected from a healthy 
animal whereas the sample 2 is from a scrapie-affected one. 
 
m/z Putative ion annotation
(a)
 Ion elemental 
formulae 
Error 
(b)
 
(ppm) 
Sample 1 Sample 2 
Rel. 
Int
(b)
 
R
2
 Rel. 
Int
(b)
 
R
2
 
180.0654 Hippuric acid + H C9H10O3N  0.8 3 0,581 nd    
202.0474 Hippuric acid + Na C9H9O3NNa 0.2 78 0,850 23 0,977 
218.0213 Hippuric acid + K C9H9O3NK 0.7 100 0,996 43 0,994 
219.0246 Hippuric acid (
13
C) + K  
13
C1C8H9O3NK 0 6 0,891 3 1.000 
220.0194 Hippuric acid +
41
K C9H9O3N
41
K 4.5 4 0,843 nd    
114.0656 Creatinine + H C4H8ON3 5.2 88 0,989 47 0,986 
136.0477 Creatinine + Na C4H7ON3Na 3.7 8 0,829 2 0,960 
152.0217 Creatinine + K C4H7ON3K 2.3 32 0,986 17 0,990 
132.0763 Creatine + H C4H10O2N3 4.0 21 1,000 10 0,981 
170.0324 Creatine + K C4H9O2N3K 1.3 5 0,998 3 0,989 
216.0631 Methyl hippuric acid + Na C10H11O3N1Na 0.4 26 0,848 3 0,983 
232.0370 Methyl-hippuric acid + K C10H11O3N1K 0.3 48 0,996 9 0,995 
425.1359 Porson + K C22H26O6K 0.5 26 0,998 nd    
175.0015 Hypoxanthine+K C5H4ON4K 1.1 4 1,000 nd    
205.0243 Ipomeanine + K C9H10O3K 9 4 0,988 nd    
(a) Only one candidate is proposed for each m/z value from DB search (putative annotation) 
(b) The mass error and relative intensity are obtained from a mass spectrum acquired at 1:2000 dilution  
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Figure S1. Plot of a) relative intensities of some ions (with low and high abundances) and b) total ion 
current (TIC) at different dilution factors (note that the TIC values are calculated from the sum of the 
relative intensities of the 30 most abundant ions). These values were reported from DI-HRMS mass 
spectra acquired from a second urine sample coming from a scrapie-affected animal.  
Different trends are observed for different ions, related to the matrix. The optimal dilution factor is 
identical to that obtained from the first urine sample coming from a healthy individual. 
 
 
 
 
 
Figure S2. Plot of RSD values calculated from absolute ion abundances of fifty most abundant peaks 
detected from the DI-HRMS mass spectra of a urine sample at a 1:2000 dilution for 20 repeated 
sample injections. The most abundant ions (>10% compared to the base peak) were marked by red 
triangles 
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Figure S3. Plot of mass measurement accuracy of the three reference compound ions using internal 
calibration from injections of 159 samples (STD1: isoniazid; STD2: PhIP and STD3: 
oxytetracycline) 
 
 
Figure S4. Plot of the seemingly power law distribution for 9684 variables detected from all urine 
samples. 122 variables shared in most samples were selected for subsequent statistical analysis. 
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Figure S5. Plot of probabilities coming from the Mahalanobis distances between every statistical 
individual and the barycenter of the 3 groups, i.e. healthy, preclinical and scrapie-infected animals. The 
SDA-mediated discrimination is typically derivated from this first classification where the minimal 
distance is retained for deciding the final assignment of a given individual to its final belonging group. 
With such a procedure based on the use of a shrinkage applied to the calculation of the correlation, the 
covariance matrices and the prior probabilities vector, all these three members entering in the calculation 
of the matrix of Mahalanobis distances, the misclassification ratio was estimated to nearly 4.5% using a 
leave-one-out procedure.  
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Figure S6. Canonical correlations calculated according to the second component (rho > 0.40). Note 
that protonated creatinine ions (m/z 114.066 annotated as C4H8ON3 and 115.068 annotated as 
13
C1C3H8ON3) display a positive correlation with scrapie-infected status whereas negative values 
were observed with samples from healthy animals or those at preclinical stage. 
 
Table S2. Putative annotation of the most discriminants biomarkers detected from the canonical 
correlation analysis reported in the Figure S5 
m/z Ion elemental formulae Error (ppm) Adduct type Putative annotation 
114.0656 C4H8ON3 5.0 M+H Creatinine 
115.0688 13C1C4H8ON3 4.3 (
13C)M+H Creatinine 
152.0217 C4H7ON3K 2.3 M+K Creatinine 
132.0762 C4H10O2N3 4.0 M+H Creatine 
170.0324 C4H9O2N3K 1.3 M+K Creatine 
173.0782 C6H14O4Na 1.6 M+Na dideoxyhexitol 
185.1148 C8H18O3Na 0.3 M+Na Octanetriol 
226.1167 C8H17N3O3 Na 2.3 M+Na Glycyl-Lysine 
232.0370 C10H11O3N1K 0.3 M+K Methyl-hippuric acid 
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